PILLOZZI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.826
EU - Europa 7.338
AS - Asia 5.488
SA - Sud America 615
AF - Africa 134
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.661
RU - Federazione Russa 2.207
IT - Italia 1.764
SG - Singapore 1.553
CN - Cina 1.395
PL - Polonia 1.394
HK - Hong Kong 820
VN - Vietnam 505
BR - Brasile 497
IE - Irlanda 474
KR - Corea 396
SE - Svezia 298
FR - Francia 271
FI - Finlandia 217
DE - Germania 198
IN - India 191
BD - Bangladesh 162
GB - Regno Unito 119
JO - Giordania 107
CA - Canada 103
ID - Indonesia 100
NL - Olanda 100
JP - Giappone 75
AU - Australia 73
AT - Austria 70
UA - Ucraina 54
CH - Svizzera 52
ES - Italia 49
AR - Argentina 45
MX - Messico 31
TR - Turchia 30
CI - Costa d'Avorio 26
ZA - Sudafrica 26
IQ - Iraq 24
BE - Belgio 22
PK - Pakistan 21
PH - Filippine 19
EC - Ecuador 17
CO - Colombia 15
NG - Nigeria 15
EG - Egitto 12
UZ - Uzbekistan 12
LT - Lituania 11
MY - Malesia 11
MA - Marocco 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 9
BJ - Benin 8
CL - Cile 8
KE - Kenya 8
PE - Perù 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
BW - Botswana 6
KZ - Kazakistan 6
NO - Norvegia 6
OM - Oman 6
UY - Uruguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
TH - Thailandia 5
AL - Albania 4
HN - Honduras 4
IR - Iran 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
TW - Taiwan 4
BB - Barbados 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LK - Sri Lanka 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GH - Ghana 2
GR - Grecia 2
JM - Giamaica 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
SC - Seychelles 2
SV - El Salvador 2
TG - Togo 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
Totale 23.459
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.164
Ashburn 1.466
Warsaw 1.388
Singapore 1.117
Hong Kong 721
Fairfield 624
Dublin 472
Chandler 405
Seoul 393
San Jose 372
Hefei 343
Seattle 313
Milan 287
Woodbridge 277
Houston 267
Florence 264
Beijing 253
Cambridge 252
Wilmington 201
Los Angeles 177
Buffalo 161
Ann Arbor 147
Ho Chi Minh City 142
Council Bluffs 139
The Dalles 139
Rome 131
Paris 121
New York 119
Dallas 118
Altamura 116
Lauterbourg 116
Lawrence 111
Hanoi 107
Munich 102
Princeton 96
Moscow 92
Helsinki 87
Jakarta 85
Mumbai 80
Boston 75
Boardman 70
Vienna 69
Melbourne 67
Tokyo 67
Shanghai 66
Kent 56
Jacksonville 55
São Paulo 48
Bern 42
Turku 41
Groningen 40
Lappeenranta 40
Pune 38
Dong Ket 34
Orem 34
London 32
Toronto 30
San Diego 29
Naples 28
Haiphong 27
Bologna 26
Clifton 26
Abidjan 25
Chennai 25
Medford 25
Turin 25
Frankfurt am Main 24
Siena 24
Bengaluru 23
Brooklyn 22
Brussels 22
Guangzhou 22
Chicago 21
Da Nang 21
Falls Church 20
Figino 20
Madrid 19
Montreal 19
Phoenix 19
Amsterdam 16
Barcelona 16
Norwalk 16
Rio de Janeiro 15
Tianjin 15
Johannesburg 14
Venice 14
Abuja 13
Brasília 13
Charlotte 13
Miano 13
Palermo 13
Brescia 12
Catania 12
Mexico City 12
Nuremberg 12
Redondo Beach 12
Atlanta 11
Stockholm 11
Verona 11
Dhaka 10
Totale 15.655
Salva come PNG Salva come JPEG
Nome #
The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression 445
hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications 347
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors 323
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway. 320
Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. 308
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 297
New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias 283
Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents 269
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 267
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 261
Ion Channels in Hematopoietic and Mesenchymal Stem Cells 257
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer 250
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 248
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 248
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 248
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 240
New gold carbene complexes as candidate anticancer agents 240
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer 240
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma 239
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 236
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 228
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer 226
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity 226
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 226
hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up 223
Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients. 221
Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors. 220
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 220
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 216
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer 214
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 212
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 210
Targeting ion channels in cancer: a novel frontier in antineoplastic therapy 207
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 207
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 205
herg1 channels are physically linked to beta 1 integrins and modulate adhesion-dependent signalling. 202
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 202
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 202
HERG K+ channels and β1 integrins interact through the assembly of a macromolecular complex 201
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer 200
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels 198
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model. 197
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 196
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 195
Searching for protein binding sites from Molecular Dynamics simulations and paramagnetic fragment-based NMR studies 194
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells 193
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 192
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 191
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 190
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 190
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 189
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 187
Somatostatin analogs in pregnant patients with neuroendocrine tumor 186
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 186
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 183
cis-Pt I2(NH3)2: a reappraisal 183
Results of the observational prospective RealFLOT study 181
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 181
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? 181
hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma 180
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma 179
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 178
Soft tissue sarcoma: An insight on biomarkers at molecular, metabolic and cellular level 178
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 178
Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas 177
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival 176
Systemic Sclerosis Association with Malignancy 176
Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe 176
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 176
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 173
Circulating miRNome profiling data in Behçet's syndrome 173
ROS1 rearrangements are uncommon in biliary tract cancers 172
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 172
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25) 169
Relationships between hepatic melanogenesis and respiratory conditions in the newt,Triturus carnifex 167
Time-resolved autofluorescence imaging of freshly excised liver biopsies using an optical fiber probe 166
Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors 166
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 166
Physical and functional interaction between integrins and hERG1 channels in cancer cells. 165
The complex between the beta1 integrin and hERG1 potassium channels as a new molecular target in antineoplastic therapy 164
Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3 164
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma 163
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 163
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 162
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) 160
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. 158
HERG K+ channels activation during beta(1) integrin-mediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1. 158
Deciphering the Renal tumOr microenvironment to PersonaLize immunE-targeted Treatment (DROPLET): transcriptomic profiling of primary and secondary lesions identified a potential crosstalk between MARCO+ macrophages and deregulated cancer-cell proliferation in mediating progression and therapy response of advanced renal cell carcinoта. 156
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy 156
The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers 155
HERG K+ channels and beta1 integrins interact through the assembly of a macromolecular complex. 154
Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis 154
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective 154
Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma 154
Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias 153
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 153
Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical–Dermoscopic and Histopathological Case–Control Study 150
Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity 148
I farmaci antiaritmici di III classe bloccano la proliferazione cellulare in cellule leucemiche inibendo i canali di K+ di tipo herg. 146
Practical tips and new trends in electrochemical biosensing of cancer-related extracellular vesicles 145
Totale 20.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.534
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 19 34 56 23 35 33 13 57 36 53 138 156
2022/20232.039 147 341 95 137 134 346 265 175 240 29 66 64
2023/20241.090 27 81 114 44 75 173 60 247 16 68 77 108
2024/20256.823 194 636 378 1.048 1.762 971 133 454 310 260 312 365
2025/20268.701 991 1.073 792 724 927 332 990 493 569 562 380 868
2026/2027239 239 0 0 0 0 0 0 0 0 0 0 0
Totale 23.737